TWI316091B - - Google Patents

Info

Publication number
TWI316091B
TWI316091B TW092134844A TW92134844A TWI316091B TW I316091 B TWI316091 B TW I316091B TW 092134844 A TW092134844 A TW 092134844A TW 92134844 A TW92134844 A TW 92134844A TW I316091 B TWI316091 B TW I316091B
Authority
TW
Taiwan
Prior art keywords
region
nontranslated
mutation
origin
vector
Prior art date
Application number
TW092134844A
Other languages
English (en)
Chinese (zh)
Other versions
TW200510534A (en
Inventor
Jun Tomono
Harumi Ueno
Masayuki Kishimoto
Hiroaki Sagawa
Ikunoshin Kato
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Publication of TW200510534A publication Critical patent/TW200510534A/zh
Application granted granted Critical
Publication of TWI316091B publication Critical patent/TWI316091B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Plant Substances (AREA)
TW092134844A 2002-12-11 2003-12-10 Cold-induced expression vector TW200510534A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002359956 2002-12-11

Publications (2)

Publication Number Publication Date
TW200510534A TW200510534A (en) 2005-03-16
TWI316091B true TWI316091B (enExample) 2009-10-21

Family

ID=32500967

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092134844A TW200510534A (en) 2002-12-11 2003-12-10 Cold-induced expression vector

Country Status (11)

Country Link
US (1) US7244588B2 (enExample)
EP (1) EP1582587B1 (enExample)
JP (1) JPWO2004053126A1 (enExample)
KR (1) KR20050085190A (enExample)
CN (1) CN100379870C (enExample)
AT (1) ATE408692T1 (enExample)
AU (1) AU2003289023B2 (enExample)
CA (1) CA2508808A1 (enExample)
DE (1) DE60323678D1 (enExample)
TW (1) TW200510534A (enExample)
WO (1) WO2004053126A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100385004C (zh) * 2002-03-01 2008-04-30 宝生物工程株式会社 冷休克诱导的异源多肽的表达和生产
AU2007339423B2 (en) * 2006-08-14 2012-11-15 Biocontrol Systems, Inc. Method for detecting pathogens
WO2024154061A1 (en) * 2023-01-18 2024-07-25 Pfizer Inc. Compositions and methods for stabilizing rna
WO2024256962A1 (en) * 2023-06-14 2024-12-19 Pfizer Inc. Method for stabilizing rna
WO2025126071A1 (en) * 2023-12-14 2025-06-19 Pfizer Inc. Rna molecules

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981280A (en) * 1996-03-22 1999-11-09 The University Of Medicine And Denistry Of New Jersey Method and constructs for inhibiting protein expression in bacteria
US5726039A (en) * 1994-07-21 1998-03-10 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Vectors and transformed host cells for recombinant protein production at reduced temperatures
US5654169A (en) * 1994-07-21 1997-08-05 Yissum Research & Development Company Of The Hebrew University Vectors and transformed host cells for recombinant protein production at reduced temperatures
ATE377647T1 (de) * 1997-11-20 2007-11-15 Takara Bio Inc Durch kälte induzierbarer expressionsvektor
AU5493599A (en) * 1998-08-20 2000-03-14 University Of Medicine And Dentistry Of New Jersey Cold-shock regulatory elements, constructs thereof, and methods of use
US6610533B1 (en) * 2000-03-01 2003-08-26 University Of Medicine And Dentistry Of New Jersey Cold-shock regulatory elements, constructs thereof, and methods of use
CN100385004C (zh) * 2002-03-01 2008-04-30 宝生物工程株式会社 冷休克诱导的异源多肽的表达和生产

Also Published As

Publication number Publication date
CA2508808A1 (en) 2004-06-24
US20060148033A1 (en) 2006-07-06
AU2003289023A1 (en) 2004-06-30
EP1582587A1 (en) 2005-10-05
WO2004053126A1 (ja) 2004-06-24
EP1582587A4 (en) 2006-10-25
US7244588B2 (en) 2007-07-17
DE60323678D1 (de) 2008-10-30
TW200510534A (en) 2005-03-16
ATE408692T1 (de) 2008-10-15
CN100379870C (zh) 2008-04-09
EP1582587B1 (en) 2008-09-17
CN1748027A (zh) 2006-03-15
AU2003289023B2 (en) 2008-07-31
JPWO2004053126A1 (ja) 2006-04-13
KR20050085190A (ko) 2005-08-29

Similar Documents

Publication Publication Date Title
CA97145S (en) Eyeglasses
WO2005045001A3 (en) Insulin-producing cells derived from stem cells
WO2005003320A3 (en) Neuronal differentiation of stem cells
AU144678S (en) Bottle
MXPA03008110A (es) Mutantes de interleucina-18, su produccion y uso.
WO2001064889A3 (en) Tnf-alpha variants for the treatment of tnf-alpha related disorders
MY133322A (en) Storage stable tablets of fosinopril sodium
GB0003930D0 (en) Cell
MX2007000334A (es) Polipeptido.
TWI316091B (enExample)
WO2003035878A3 (de) Lipase-varianten
CA97550S (en) Golf bag
WO2005094185A3 (en) Recombinant calf-chymosin and a process for producing the same
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
SE0003576D0 (sv) New strain
TW200613271A (en) Crystalline forms of 1,24(s)-dihydroxy vitamin d2
TW200504218A (en) Methods for preventing gluconoylation of proteins
HK1052533A1 (zh) 细胞外的基层蛋白质
IL163651A0 (en) Nucleotide sequence coding for a tolc and a defined amino acid sequence
TW200519206A (en) Methods for producing novel medaka and novel medaka
TH62143S (th) ธูปเส้น (ชนิดไม่มีก้าน) (ธูปตัน)
TH19918S1 (th) ขวด
TH69211S (th) ขวด
CA104574S (en) Bottle top
TH22594S1 (th) ขวด

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees